Completed Substance Misuse To Psychosis for Stimulants NCT03485417 Conditions Disease, Mental Disorders, Pathologic Processes, +9 more Locations Queen Mary Hospital — Hong Kong View Trial Details
Completed Pilot TMS for Methamphetamine Use Disorder NCT04449055 Conditions Addiction, Drug, Chemically-Induced Disorders, Mental Disorders, +3 more Locations University of Iowa — Iowa City, Iowa, United States View Trial Details
Completed CRAFT Behavior Therapy: Treatment Entry Component NCT00842036 Conditions Alcohol Dependence, Alcohol-Related Disorders, Alcoholism, +9 more Locations TRI South Street — Philadelphia, Pennsylvania, United States View Trial Details
Completed Mindfulness Based Relapse Prevention for Stimulant Users NCT01094223 Conditions Behavior, Behavior, Addictive, Compulsive Behavior, +2 more Locations UCLA — Los Angeles, California, United States View Trial Details
Completed Atomoxetine for ATS and Opioid Dependence During Buprenorphine Maintenance Treatment in Malaysia NCT01863251 Conditions Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +4 more Locations Universiti Sains Malaysia — Kota Bharu, Malaysia View Trial Details
Completed An Eval of Neurocognitive Function, Oxidative Damage, and Their Association With Outcomes in METH and Cocaine Abusers. NCT00628927 Conditions Stimulant Dependence Locations Gateway Community Services — Jacksonville, Florida, United States Maryhaven — Columbus, Ohio, United States Willamette Family Treatment Services — Eugene, Oregon, United States ChangePoint, Inc. — Portland, Oregon, United States View more locations Show fewer locations Loading locations... View Trial Details
